Before Mailing, register your DNA kit at 23andMe online otherwise, your saliva sample will NOT be processed. 23andMe provides the best DNA-based ancestry test kit with the most comprehensive ancestry breakdown and 30+ trait reports. Discover how your DNA ancestry contributes to certain traits and characteristics that make you, you. Easily upgrade to 23andMe's Health + Ancestry Service at any time for an extra cost and receive access to 65 health and wellness reports. See how your DNA breaks out across over 3,000 regions worldwide. Learn about your ancestral origins and see where your ancestors lived 500+ years ago. Travel the world based on your DNA. Find out where your DNA comes from using your ancestry test – and use that discovery to create the ultimate itinerary. 23andMe's Family Tree is automatically built from your DNA relationships. It’s easy. It’s convenient. It’s just a click away. Opt-in to DNA Relatives to connect with people who share DNA with you - and message them! Discover and meet living DNA relatives from around the world and get a better understanding of your family history. Understand how the migration of our DNA tells the story of your ancestors with the Haplogroups report. This ancestry test kit will help you explore genetic similarities and differences between you and your relatives. Compare genetic similarities and differences between you and your genotyped relatives. See how different ancestries have traveled through generations of your family. Neanderthal Ancestry uncovers how much Neanderthal DNA you inherited and how your Neanderthal composition compares to others. Gain access to over 30+ traits reports, including: Hair (Color, Curliness, Male Bald Spot), Taste & Smell (Sweet vs. Salty, Bitter), Facial Features (Cheek Dimples, Unibrow, Freckles). 23andMe Ancestry Service includes DNA ancestry reports and empowers you to learn more accurately about your ethnicity, genealogy, family lineage, and traits that make you, you!

* The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Visit 23andMe for important test information.

**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Our SLCO1B1 Pharmacogenetics report provides certain information about variants associated with the processing of some therapeutics and provides interpretive drug information regarding the potential effect of simvastatin therapy. Our DPYD Pharmacogenetics report does not describe the association between detected variants and any specific therapeutic. Results for DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. Visit 23andMe for important Pharmacogenetics information.

Before you can use 23andMe services and see your reports, you must agree to 23andMe's Terms of Service and 23andMe’s Privacy Statement at the time of kit registration.